Ulf Wikesjö of the Medical College of Georgia has demonstrated impressive osseous regeneration around dental implants coated with recombinant human Bone Morphogenic Protein (rhBMP-2). Dr. Wikesjö is researching wound-healing and tissue regeneration with a $1.4 million grant from Nobel Biocare. In laboratory tests, rhBMP-2 applied onto implants directs endogenous stem cells to become bone-forming cells. The result was a nearly complete regeneration of lost tissue. He hopes to start clinical trials in the summer of 2006.
Welcome to OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.